Literature DB >> 18581336

Molecular mimicry in innate immunity? The viral RNA recognition receptor TLR7 accelerates murine lupus.

Hans-Joachim Anders1, Anne Krug, Rahul D Pawar.   

Abstract

Toll-like receptors (TLR), such as TLR7, were first described as innate pathogen recognition receptors that trigger appropriate antimicrobial immune responses upon exposure to pathogen-associated molecules, e.g. viral ssRNA. In parallel to ongoing studies on TLR-biology, mounting experimental evidence suggests that endogenous RNA-related autoantigens may also activate dendritic cells (DC) and B cells through TLR7. TLR7-mediated DC activation, autoantibody secretion, lymphoproliferation, and autoimmune tissue injury, are frequently observed in various murine models of systemic lupus and lupus nephritis. A paper in the current issue of the European Journal of Immunology, provide striking experimental evidence for this concept; the authors show that the Y chromosome-linked autoimmune accelerating (Yaa) translocation from the X-chromosome, consisting of 16 genes including Tlr7, largely mediates the autoimmune phenotype via the duplication of Tlr7. This finding highlights the need to address the significance of TLR7 in human lupus in terms of both genetic risk and as a therapeutic option.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18581336     DOI: 10.1002/eji.200838478

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

1.  IRF4 deficiency abrogates lupus nephritis despite enhancing systemic cytokine production.

Authors:  Maciej Lech; Marc Weidenbusch; Onkar P Kulkarni; Mi Ryu; Murthy Narayana Darisipudi; Heni Eka Susanti; Hans-Willi Mittruecker; Tak W Mak; Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2011-07-08       Impact factor: 10.121

2.  Mdm2 promotes systemic lupus erythematosus and lupus nephritis.

Authors:  Ramanjaneyulu Allam; Sufyan G Sayyed; Onkar P Kulkarni; Julia Lichtnekert; Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2011-09-23       Impact factor: 10.121

Review 3.  A novel pathogenetic concept-antiviral immunity in lupus nephritis.

Authors:  Adriana Migliorini; Hans-Joachim Anders
Journal:  Nat Rev Nephrol       Date:  2012-01-17       Impact factor: 28.314

4.  VISA is required for B cell expression of TLR7.

Authors:  Liang-Guo Xu; Lei Jin; Bi-Cheng Zhang; Linda J Akerlund; Hong-Bing Shu; John C Cambier
Journal:  J Immunol       Date:  2011-11-21       Impact factor: 5.422

5.  No evidence for a genetic association of IRF4 with systemic lupus erythematosus in a Chinese population.

Authors:  S-S Liu; D Ye; J Lou; Z Fan; D-Q Ye
Journal:  Z Rheumatol       Date:  2014-08       Impact factor: 1.372

6.  Sex Differences in monocytes and TLR4 associated immune responses; implications for systemic lupus erythematosus (SLE).

Authors:  Wei Jiang; Gary Gilkeson
Journal:  J Immunother Appl       Date:  2014-03-07

7.  Toll-like receptor and accessory molecule mRNA expression in humans and mice as well as in murine autoimmunity, transient inflammation, and progressive fibrosis.

Authors:  Santhosh Kumar Vankyala Ramaiah; Roman Günthner; Maciej Lech; Hans-Joachim Anders
Journal:  Int J Mol Sci       Date:  2013-06-26       Impact factor: 5.923

Review 8.  Toll-like receptors in lupus nephritis.

Authors:  Satish Kumar Devarapu; Hans-Joachim Anders
Journal:  J Biomed Sci       Date:  2018-04-12       Impact factor: 8.410

Review 9.  Belimumab or anifrolumab for systemic lupus erythematosus? A risk-benefit assessment.

Authors:  Kyriakos A Kirou; Maria Dall Era; Cynthia Aranow; Hans-Joachim Anders
Journal:  Front Immunol       Date:  2022-08-31       Impact factor: 8.786

10.  Toll-like receptor 2 or toll-like receptor 4 deficiency does not modify lupus in MRLlpr mice.

Authors:  Simon J Freeley; Angela Giorgini; Calogero Tulone; Reena J Popat; Catherine Horsfield; Michael G Robson
Journal:  PLoS One       Date:  2013-09-24       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.